Omar Khalil

Director/Miembro de la Junta en

Solu Therapeutics

Health Technology

Commercial Services

Consumer Services

Perfil

Omar Khalil is currently Managing Director at SHVMS, LLC since 2024.
Mr. Khalil is Director at Geneos Therapeutics, Inc. since 2023.
Mr. Khalil is Director at Kestrel Therapeutics, Inc. since 2022.
Mr. Khalil is Director at Solu Therapeutics, Inc. since 2023.
Mr. Khalil is Board Member at MycRX since 2021.
Former roles include Vice President & US Hospital Products at Baxter International, Inc. from 2015 to 2017, Vice President & General Manager at Kaleo, Inc. from 2017 to 2020, and Principal at McKinsey & Co., Inc. Education includes undergraduate and graduate degrees from the University of Michigan.

Cargos activos de Omar Khalil

Empresas	Cargo	Inicio
SHVMS, LLC SHVMS, LLC Investment ManagersFinance Sante Ventures invests in companies located in the United States. The firm targets companies operating in the fields of medical technologies, biotechnology, healthcare services and healthcare IT. It provides financing for seed and early-stage capital requirements.	Inversor de Capital Privado	01/01/2020
Kestrel Therapeutics, Inc. Kestrel Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology development company	Director/Miembro de la Junta	01/01/2022
Solu Therapeutics Solu Therapeutics BiotechnologyHealth Technology Operates as a biotechnology that develops therapeutics to eliminate disease-driving cells in cancer, immunology and autoimmunity	Director/Miembro de la Junta	01/01/2023
MycRx MycRx Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops small molecule inhibitors of the Myc oncoprotein	Director/Miembro de la Junta	01/01/2021
Geneos Therapeutics, Inc. Geneos Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes neo-antigen based personalized cancer therapies	Director/Miembro de la Junta	01/01/2023

Todos los cargos activos de Omar Khalil

Antiguos cargos conocidos de Omar Khalil.

Empresas	Cargo	Fin
Kaleo, Inc. Kaleo, Inc. Pharmaceuticals: MajorHealth Technology Develops drug or device combination products	Inversor de Capital Privado	01/01/2020
BAXTER INTERNATIONAL INC.	Corporate Officer/Principal	01/01/2017
McKinsey & Co., Inc. McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm	Corporate Officer/Principal	-

Ver el detalle de la experiencia de Omar Khalil.

Formación de Omar Khalil.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Omar Khalil.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	9
Baxter International, Inc. Baxter International, Inc. Medical SpecialtiesHealth Technology Produces and supplies medical products, healthcare systems, therapies and pharmaceuticals & provide kidney care services	Health Technology
Kaleo, Inc. Kaleo, Inc. Pharmaceuticals: MajorHealth Technology Develops drug or device combination products	Health Technology
McKinsey & Co., Inc. McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm	Commercial Services
University of Michigan University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
SHVMS, LLC SHVMS, LLC Investment ManagersFinance Sante Ventures invests in companies located in the United States. The firm targets companies operating in the fields of medical technologies, biotechnology, healthcare services and healthcare IT. It provides financing for seed and early-stage capital requirements.	Finance
Geneos Therapeutics, Inc. Geneos Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes neo-antigen based personalized cancer therapies	Health Technology
Kestrel Therapeutics, Inc. Kestrel Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology development company	Commercial Services
MycRx MycRx Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops small molecule inhibitors of the Myc oncoprotein	Commercial Services
Solu Therapeutics Solu Therapeutics BiotechnologyHealth Technology Operates as a biotechnology that develops therapeutics to eliminate disease-driving cells in cancer, immunology and autoimmunity	Health Technology